Pulmonary Diseases CEU Courses for Respiratory Therapists

We recognize the familiar phenotypes of asthma – exercise-induced bronchoconstriction(EIB), allergic, occupational, non-allergic, etc. However, understanding why patients with EIB, for example, may respond differently to the same treatment remains unclear. Identifying the mechanism behind the condition should, ideally, allow for precise - targeted treatment of these patients.

Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease affecting individuals worldwide. This advanced course provides familiarity with current literature findings in epidemiology, pathology, and diagnosis of IPF. In addition, this course reviews future therapeutic directions and clinical applications for best practice and management.

An introductory course on autogenic drainage introduces the practitioner to this airway clearance technique focusing on the indications, procedure, and monitoring of patient outcomes.

This intermediate course focuses on increasing the understanding and application of the assessment of the patient with chronic obstructive pulmonary disease. The course reviews the objective tests of function and patient-reported outcomes (PROs), which can provide valuable information on patient status and progress within disease management programs.

This intermediate course provides a physiologic overview and evidence-based considerations of cardiovascular disease management in respiratory care. The course is designed to provide the listener with additional perspective and understanding in the critical care of patients with cardiovascular comorbidity.

This course provides the steps in the identification of COVID-19 infection vs. chronic lung disease exacerbations, including the evolvement of management strategies for improving oxygenation and ventilator support for COVID-19 patients. The Biopsychosocial impact of this virus on the elderly and those with chronic lung disease is discussed.

This advanced course is designed to guide respiratory therapists in the key components of asthma education when teaching patients and their families. The information presented in the webinar consists of relevant research, evidenced-based national asthma guidelines for clinical application, as well as the experience and training of the presenter.

This intermediate course covers the current, evidence-based guidelines for the diagnosis, treatment, and rehabilitation of stable COPD and exacerbations of COPD. Course materials are provided by the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

This advanced course focuses on the progression of "long COVID of the lungs," identifying current post-acute sequelae of the SARS-CoV-2 infection (PASC) involving the lungs with special focus on pulmonary fibrosis. The course reviews evidence-based literature on diagnosis and treatment intervention and post-COVID-19 initiatives for best practice management of pulmonary PASC.

New treatments for COPD have emerged for patients with emphysema and chronic bronchitis. This course provides an overview of these new therapies and where they may be applied now and in the future.